D453-0718 Screening compound: 3-(1H-1,2,3,4-tetrazol-1-yl)phenyl 2,2-diphenylacetate

D453-0718 Screening compound: 3-(1H-1,2,3,4-tetrazol-1-yl)phenyl 2,2-diphenylacetate
D453-0718 Screening compound: 3-(1H-1,2,3,4-tetrazol-1-yl)phenyl 2,2-diphenylacetate alternative view

Chemical Structure Depiction of ChemDiv screening compound D453-0718
3-(1H-1,2,3,4-tetrazol-1-yl)phenyl 2,2-diphenylacetate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D453-0718

Molecular Formula

C21H16N4O2 (C21 H16 N4 O2)

Compound Name

3-(1H-1,2,3,4-tetrazol-1-yl)phenyl 2,2-diphenylacetate

IUPAC name

3-(1H-1234-tetrazol-1-yl)phenyl 22-diphenylacetate

SMILES

O=C(C(c1ccccc1)c1ccccc1)Oc1cc(-n2nnnc2)ccc1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

356.38

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.234

Distribution Coefficient, logD

4.234

Water Solubility, LogSw

-4.66

Polar Surface Area

60.110

Acid Dissociation Constant (pKa)

13.91

Base Dissociation Constant (pKb)

-2.44

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

4.80

D453-0718 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

DGK Inhibitors Library (10558 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

RAR (Nuclear receptors) Ligands Library (6524 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Cancer
  • Respiratory tract
  • Eye
  • Male
  • Female
  • Hemic and lymphatic
  • Congenital
  • Skin
  • Endocrine
  • Immune system
Targets:
  • Kinases
  • Others
  • Nuclear receptors
Mechanism of action:
  • Epigenetic
  • Receptor's ligands

References: we are preparing a list of scientific research reports with D453-0718 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D453-0718?
Check Price and Availability of D453-0718, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D453-0718 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D453-0718
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D453-0718
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D453-0718 available by request